Rifampin Injection · #17 of 35 active shortages by FDA posting duration
Brand: RIFAMPIN
FDA lists Rifampin Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Rifampin Injection: Active Shortage
Available 12 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Rifampin Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Rifampin, Injection, 600 mg (NDC 63323-351-20)
- Package NDC
- 63323-351-20
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Feb 17, 2021
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Anti-Infective
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory
Full Drug Profile
rifampin
Side effects, interactions, warnings & more
Nearby, Other Rifampin Shortage Records
Rifampin Injection
Sanofi-Aventis U.S. LLC
Injection
Rifampin Injection
Mylan Institutional, a Viatris Company
Injection
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule
FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.